Change in potentially modifiable categorically-measured characteristics and antihypertensive use from baseline to follow-up^a.

aData presented as No. (%). bMaximum n, with small amounts of data missing for some factors for either baseline or follow-up. cResults comparing reverters and non-reverters. dChange between abstainer, ≤1 drink/day, and >1 drink/day. eChange between <5, 5–10, and >10 contacts/month.